Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Denali Therapeutics Inc. Common Stock | DNLI

Daily Technical Analysis of Denali Therapeutics Inc. Common Stock

Denali Therapeutics dropped to day and moved down -3.41%

The Biotechnology company isn't at an immediate support or resistance level that might be predictive. DNLI has been bouncing around but hasn't taken a very clear direction over the last few months. So it doesn't have very much obvious momentum in either direction. DNLI might find some support at the 29.27 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for Denali Therapeutics By Price Target And Rating

The balance of viewpoints by the analysts is positive. The current Analysts Sentiment Score is 67.96. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-02-29 The Goldman Sachs Group lowered their price target by -31.51% to $50.00. HC Wainwright announced a lowering of their price target to $95.00 from $105.00 on 2024-02-28. On 2024-02-28 there was confirmation of the previous rating by Wedbush which was Outperform and provided a price target of $31.00. Citigroup initiated a rating of Buy on 2023-12-13 and provided a price target of $32.00. JPMorgan Chase & Co. announced that they are reiterating a rating of Overweight on 2023-11-20 and they set their price target at $28.00. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-10-24 and dropped their 1 year price target to $35.00 which is down from $85.00. On 2023-09-06 B. Riley initiated their coverage and rated as Buy and added a price target of $38.00. On 2023-05-09 Stifel Nicolaus decreased their price target to 30.00. Morgan Stanley gave a boost to their price target and moved to $63.00 from $61.00 on 2023-04-12. Oppenheimer announced a lowering of their price target to $70.00 from $85.00 on 2023-03-02.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
DNLI67.96114.15082.58-60.82

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-11)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
DNLI0.000.00

Short interest for Denali Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
DNLI11.24%8.813.7-0.2649520000

How Denali Therapeutics compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
104-1.67-0.41-9.870.5839.0115.3437.2633.1813.7412.82-13905.94-11063.753.3724.049.5869.46
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
247-1.001.26-7.93-1.6324.465.3441.5531.3310.6811.04-12888.05-11534.394.9617.316.9348.19

Social Sentiment for Denali Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
DNLI

Companies with the highest correlation to Denali Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
RCKT | Rocket Pharmaceuticals, I1.29-0.170.64-13.28-18.4032.3832.983812.1832.4236.89-2746.04-17665.95009.12889
SAGE | Sage Therapeutics, Inc1.128.117.40-26.47-45.95-26.74-70.4327-22.06-22.77-15.93-51237.60-1298.120012.6533
EXAS | Exact Sciences Corp1.1-0.46-0.38-5.44-3.71-3.83-0.4946-36.35-38.66-24.05-14136.19-7085.87005.2321
PTCT | PTC Therapeutics, Inc.1.09-0.792.11-14.37-5.088.57-50.7643-7.53-9.10-18.81-2130.48-3383.27007.10334
VCYT | Veracyte, Inc.1.080.353.65-8.38-22.69-7.27-9.8716-6.77-4.31-2.36-13628.83-197.9801254.97884
TWST | Twist Bioscience Corporat1.06-2.388.43-10.82-7.3885.46140.612026.2150.7192.05-7098.72-10006.210023.3961

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-